According to MeiraGTx's latest financial reports the company has a price-to-book ratio of 19.1668.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2025-12-31 | N/A | -100% |
2024-12-31 | 7.16 | 121.46% |
2023-12-31 | 3.23 | 20.36% |
2022-12-31 | 2.68 | -52.83% |
2021-12-31 | 5.69 | 102.95% |
2020-12-31 | 2.80 | -27.35% |
2019-12-31 | 3.86 | 18.53% |
2018-12-31 | 3.26 | |
2017-12-31 | N/A |
Company | P/B ratio | P/B ratio differencediff. | Country |
---|---|---|---|
![]() Novocure
NVCR | 3.60 | -82.01% | Jersey |
![]() Novavax NVAX | -15.6 | -178.01% | ๐บ๐ธ USA |
![]() Organovo ONVO | 0.3500 | -98.25% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | 4.74 | -76.30% | ๐ฌ๐ง UK |